Mount Yale Investment Advisors LLC Purchases 4,588 Shares of Aflac Incorporated (NYSE:AFL)

Mount Yale Investment Advisors LLC grew its position in Aflac Incorporated (NYSE:AFL) by 33.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 18,249 shares of the financial services provider’s stock after acquiring an additional 4,588 shares during the quarter. Mount Yale Investment Advisors LLC’s holdings in Aflac were worth $1,630,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Frank Rimerman Advisors LLC raised its stake in shares of Aflac by 116.3% in the second quarter. Frank Rimerman Advisors LLC now owns 12,591 shares of the financial services provider’s stock valued at $1,125,000 after purchasing an additional 6,769 shares in the last quarter. ProShare Advisors LLC increased its holdings in Aflac by 5.6% in the 2nd quarter. ProShare Advisors LLC now owns 2,220,125 shares of the financial services provider’s stock valued at $198,279,000 after buying an additional 117,504 shares during the period. Hancock Whitney Corp acquired a new position in shares of Aflac in the 2nd quarter valued at $204,000. Symmetry Investments LP lifted its holdings in shares of Aflac by 147.2% during the 2nd quarter. Symmetry Investments LP now owns 8,162 shares of the financial services provider’s stock worth $729,000 after acquiring an additional 4,860 shares during the period. Finally, Legacy Financial Advisors Inc. acquired a new stake in shares of Aflac during the 2nd quarter valued at about $220,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Wall Street Analysts Forecast Growth

AFL has been the subject of several recent research reports. JPMorgan Chase & Co. increased their price target on shares of Aflac from $80.00 to $83.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 2nd. Wells Fargo & Company raised their target price on Aflac from $81.00 to $90.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. Truist Financial upped their price target on Aflac from $82.00 to $100.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Piper Sandler lifted their price objective on Aflac from $95.00 to $100.00 and gave the company an “overweight” rating in a report on Friday, June 28th. Finally, UBS Group upped their target price on shares of Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a report on Wednesday, August 14th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $92.50.

Insider Buying and Selling

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total transaction of $197,880.00. Following the transaction, the director now directly owns 18,158 shares in the company, valued at approximately $1,796,552.52. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.90% of the company’s stock.

Aflac Trading Up 0.0 %

AFL opened at $107.92 on Monday. Aflac Incorporated has a 1-year low of $74.89 and a 1-year high of $111.14. The firm has a 50-day moving average price of $102.88 and a two-hundred day moving average price of $92.03. The stock has a market capitalization of $61.32 billion, a PE ratio of 11.91, a PEG ratio of 2.53 and a beta of 0.95. The company has a current ratio of 0.10, a quick ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.23. The firm had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $4.10 billion. Aflac had a net margin of 28.35% and a return on equity of 16.22%. Aflac’s revenue was down .7% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.58 EPS. As a group, equities analysts anticipate that Aflac Incorporated will post 6.75 earnings per share for the current fiscal year.

Aflac Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.85%. The ex-dividend date of this dividend was Wednesday, August 21st. Aflac’s dividend payout ratio (DPR) is presently 22.08%.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.